Lonapegsomatropin (Skytrofa)
Overview
Lonapegsomatropin is a long-acting prodrug of somatropin created through site-specific PEGylation that releases active growth hormone after administration. The PEG moiety extends circulating half-life and enables once-weekly dosing for pediatric growth hormone deficiency.
Mechanism of Action
This represents a transient modification strategy in which the PEG is cleaved to yield native growth hormone..
Research Summary & Key Findings
The Phase 3 enliGHten trial published in Lancet Child & Adolescent Health in 2021 demonstrated non-inferiority to daily somatropin in improving annualized height velocity in children with growth hormone deficiency. FDA approval was granted in August 2021 for pediatric patients aged one year and older. Safety and efficacy profiles were comparable to conventional daily somatropin formulations.
Clinical Status
Lonapegsomatropin (Skytrofa) has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.
Administration Routes
Related Peptides in Hormone
CJC-1295
In Clinical TrialsA synthetic analog of growth hormone-releasing hormone (GHRH) with a Drug Affinity Complex (DAC) that binds to albumin, ...
View detailsIpamorelin
In Clinical TrialsA highly selective growth hormone secretagogue that acts on ghrelin/GHS receptors in the pituitary gland to stimulate GH...
View detailsSermorelin
FDA ApprovedA synthetic 29-amino acid analog of GHRH representing the shortest fully functional fragment of the native 44-amino acid...
View detailsTesamorelin (Egrifta)
FDA ApprovedA synthetic GHRH analog consisting of the 44-amino acid sequence of human GHRH with a trans-3-hexenoic acid modification...
View detailsFind a Provider
Find a verified provider who offers Lonapegsomatropin (Skytrofa) therapy in your area.
Browse Provider MapFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Lonapegsomatropin (Skytrofa).
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.